We offer TMS treatment for depression and anxiety that has not responded to medication. New Chapter TMS utilizes a Neurostar machine, which is the most popular and most effective brand of TMS machine.

Neuronetics Inc. (NASDAQ:STIM) is one of the best-performing NASDAQ stocks according to analysts. On June 10, Neuronetics announced its significant presence at the 13th Annual Clinical TMS Society ...

Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for ...

As access to NeuroStar TMS grows, more families will have the opportunity to pursue effective treatments for depression, addressing a critical need in the U.S. mental health landscape.

Neuronetics announced that Evernorth will offer coverage for its NeuroStar Transcranial Magnetic Stimulation (TMS) therapy to patients aged 15 and older who have major depressive disorder.

MALVERN, Pa., May 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of ...

The Food and Drug Administration (FDA) has cleared NeuroStar ® Advanced Therapy for use as an adjunct in the treatment of major depressive disorder (MDD) in patients 15 to 21 years of age ...

NeuroStar Advanced Therapy is the leading transcranial magnetic stimulation (TMS) treatment for MDD in adults with over 5.9 million treatments delivered.

NeuroStar also participated in the PULSES Course, a foundational training session for TMS providers, and exhibited at booth #303. Additionally, Neuronetics provided an update on Greenbrook Mental ...